Physician profile
Henry Cabrera
NPI 1750549622
$1,169.79
in general payments reported to CMS, 2019-2025
9 companies · $265 in 2025
The $265 reported for 2025 was more than what 85% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $114 · 2020: $24.96 · 2021: $51.93 · 2022: $63.76 · 2023: $316 · 2024: $334 · 2025: $265.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $915.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $915.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $277.41 | 2020-2025 | Entyvio |
| Merck Sharp & Dohme LLC | $258.02 | 2022-2025 | Bridion |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $222.90 | 2022-2024 | Trulance |
| Alnylam Pharmaceuticals INC. | $141.29 | 2024-2025 | Givlaari |
| Comsort, INC | $100.00 | 2019 | |
| Janssen Biotech, INC. | $99.66 | 2023-2025 | Stelara, Tremfya, Remicade |
| Intercept Pharmaceuticals, INC. | $34.67 | 2023-2024 | Ocaliva |
| Acacia Pharma INC | $21.75 | 2022 | |
| Cook Medical LLC | $14.09 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Henry Cabrera listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.